Cerebrospinal Fluid Markers of Medium Spiny Neuron Injury in Huntington's Disease
- PMID: 33599006
- DOI: 10.1002/mds.28386
Cerebrospinal Fluid Markers of Medium Spiny Neuron Injury in Huntington's Disease
Comment on
-
Cerebrospinal Fluid Levels of Prodynorphin-Derived Peptides are Decreased in Huntington's Disease.Mov Disord. 2021 Feb;36(2):492-497. doi: 10.1002/mds.28300. Epub 2020 Oct 2. Mov Disord. 2021. PMID: 33006791
-
Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease.Mov Disord. 2021 Feb;36(2):481-491. doi: 10.1002/mds.28391. Epub 2020 Nov 28. Mov Disord. 2021. PMID: 33247616 Free PMC article.
References
-
- Ross CA, Aylward EH, Wild EJ, et al. Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol 2014;10(4):204-216.
-
- Kronenbuerger M, Hua J, Bang JYA, et al. Differential changes in functional connectivity of striatum-prefrontal and striatum-motor circuits in Premanifest Huntington's disease. Neurodegener Dis 2019;19(2):78-87.
-
- Blumenstock S, Dudanova I. Cortical and striatal circuits in Huntington's disease. Front Neurosci 2020;14:82.
-
- Tabrizi SJ, Flower MD, Ross CA, Wild EJ. Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities. Nat Rev Neurol 2020;16(10):529-546.
-
- Paulsen JS, Nopoulos PC, Aylward E, et al. Striatal and white matter predictors of estimated diagnosis for Huntington disease. Brain Res Bull 2010;82(3-4):201-207.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical